Volume 46, Issue 3 (9-2022)
Research in Medicine 2022, 46(3): 41-49 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mohammadyari M, Mozaffari Z, Rahimian Zarif B. Investigation of the Inhibitory Effect of Zinc Nanoparticles on Pseudomonas aeruginosa. Research in Medicine 2022; 46 (3) :41-49
URL: http://pejouhesh.sbmu.ac.ir/article-1-3071-en.html
URL: http://pejouhesh.sbmu.ac.ir/article-1-3071-en.html
Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran. , Mozaffari_Ziba882@yahoo.com
Abstract: (1152 Views)
Background and Aim: Nowadays, the use of metals such as silver, copper, gold, and aluminum in various forms including nanoparticles as antimicrobial and bactericidal compounds has become popular. The present study aimed to evaluate the effect of zinc nanoparticles on Pseudomonas aeruginosa (ATCC 27853).
Methods: In the current experimental study, zinc nanoparticles prepared from Nano Pars Co. Pseudomonas aeruginosa ATCC 27853 was used as the indicator microorganism. The antibacterial activity of nano-particles was compared with benzalkonium using agar diffusion (disk diffusion) and dilution methods. Data were statistically analyzed using SPSS software, version 22 (IBM, Armonk, NY, USA) running one way ANOVA and Tukey test.
Results: The results showed that the addition of zinc nanoparticles to the benzalkonium chloride solvent increased the diameter of the inhibitory zone of Pseudomonas spp. from 9±1 to 19.66 ± 3.05 )P-value =0.001). The MIC and MBC for zinc nanoparticles were 0.15 and 0.24 mg/ml, respectively, while the MIC and MBC for nanoparticles of zinc+benzalconium chloride 10% were 0.03 and 0.04, respectively. This indicates the excellent antibacterial activity of nanoparticles in combination with benzalkonium chloride solvent against Pseudomonas spp.
Conclusion: It seems that the stock of nanoparticles with benzalkonium chloride solvent has bactericidal or growth inhibitory effect against Pseudomonas aeruginosa in different concentrations and has rapid bactericidal effect in concentrations higher than MIC concentration. Zinc oxide nanoparticles can be used to prevent or help treat Pseudomonas aeruginosa infections.
Methods: In the current experimental study, zinc nanoparticles prepared from Nano Pars Co. Pseudomonas aeruginosa ATCC 27853 was used as the indicator microorganism. The antibacterial activity of nano-particles was compared with benzalkonium using agar diffusion (disk diffusion) and dilution methods. Data were statistically analyzed using SPSS software, version 22 (IBM, Armonk, NY, USA) running one way ANOVA and Tukey test.
Results: The results showed that the addition of zinc nanoparticles to the benzalkonium chloride solvent increased the diameter of the inhibitory zone of Pseudomonas spp. from 9±1 to 19.66 ± 3.05 )P-value =0.001). The MIC and MBC for zinc nanoparticles were 0.15 and 0.24 mg/ml, respectively, while the MIC and MBC for nanoparticles of zinc+benzalconium chloride 10% were 0.03 and 0.04, respectively. This indicates the excellent antibacterial activity of nanoparticles in combination with benzalkonium chloride solvent against Pseudomonas spp.
Conclusion: It seems that the stock of nanoparticles with benzalkonium chloride solvent has bactericidal or growth inhibitory effect against Pseudomonas aeruginosa in different concentrations and has rapid bactericidal effect in concentrations higher than MIC concentration. Zinc oxide nanoparticles can be used to prevent or help treat Pseudomonas aeruginosa infections.
Type of Study: Original |
Subject:
Microbiology
Received: 2021/07/18 | Accepted: 2022/02/8 | Published: 2023/01/2
Received: 2021/07/18 | Accepted: 2022/02/8 | Published: 2023/01/2
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This Journal is licensed under a Creative Commons Attribution 4.0 International License | Research in Medicine
Designed & Developed by : Yektaweb